New theory: What causes severe COVID and long-haul symptoms? kare11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kare11.com Daily Mail and Mail on Sunday newspapers.
Nearly $100M in Long COVID Funding Introduced in Congress
Historic bipartisan act focuses on research, treatment, disparities of debilitating diseases affecting millions of Americans
News provided by
Share this article
Share this article
LOS ANGELES, May 27, 2021 /PRNewswire/ Rep. Don Beyer (D-VA) and Rep. Jack Bergman (R-MI) have introduced the historic COVID-19 Long Haulers Act (H.R. 2754) bipartisan legislation authorizing and funding research and education initiatives benefiting so-called long haulers, an estimated 25–35% of COVID-19 patients who experience long-term effects of the virus.
Solve M.E. and members of the Long COVID Alliance worked closely with Representative Beyer s office to help craft data-driven policy solutions that meet the diverse needs of ALL long haulers and post-infectious illness patients.
GB Sciences Featured & Speaking at the SACHS Associates 4th Annual Neuroscience Innovation Forum
LAS VEGAS, NV / ACCESSWIRE / April 27, 2021 / GB Sciences (GBS), Inc. (OTCQB:GBLX), a leading phytomedicine research and biopharmaceutical development company, will be featured during the SPOTLIGHT SHOWCASE at the SACHS Associates 4th Annual Neuroscience Innovation Forum (NIF) for Business Development, Licensing & Investment from April 28 to April 30. The SACHS NIF, which is entirely virtual, will include a SPOTLIGHT SHOWCASE session describing GB Sciences recent pivot and novel drug development pipeline. In addition, Dr. Andrea Small-Howard, the Chief Science Officer and Director of GB Sciences, is an invited speaker on the Pain, Migraines, and Addiction Panel during a live session on Therapeutics Day 2, April 29 at 11:50 a.m. EDT.
GB Sciences Featured & Speaking at the SACHS Associates 4th Annual Neuroscience Innovation Forum tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Press release content from Newswire. The AP news staff was not involved in its creation.
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
April 20, 2021 GMT
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
LAS VEGAS - April 20, 2021 - ( Newswire.com )
GB Sciences, Inc. (OTCQB: GBLX) and Purisys, LLC, the global industry leader in ultra-high purity, pharmaceutical grade cannabinoid supply, today announced that GB Sciences has selected Purisys as their preferred vendor for the active pharmaceutical ingredients (“APIs”) used in formulating GB Sciences’ proprietary, cannabinoid-containing, optimized therapeutic mixtures (OTM).
“To achieve standardization in our cannabinoid-containing, optimized therapeutic mixtures, GB Sciences is moving away from using materials extracted from the cannabis plant in favor of OTM formulations incorporating ident